How funds voted at Carisma Therapeutics Inc.
- Filers reporting
- 6, year to 30 June 2026
- Latest meeting on file
- Meetings on file
- 2
In the year to 30 June 2026, 6 filers on Form N-PX reported votes at Carisma Therapeutics Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
In the year to 30 June 2026, no say-on-pay item is on file for Carisma Therapeutics Inc.. So there is no figure to give.
By filers reporting in the year to 30 June 2026, Carisma Therapeutics Inc. was number 11,924 of 11,972 companies with a page and votes in that year. No filer reported votes at Carisma Therapeutics Inc. in the year to 30 June 2025, so this page gives no change from that year. In all seasons on file, category SECTION 14A SAY-ON-PAY VOTES is 41.2% of the vote records at Carisma Therapeutics Inc.. At all companies on this site, it is 12.3%.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2026. Filings read through . How the figures are made
Since the last update
The site has recorded no change in the tracked figures of this page.
Tracked: the meetings on file and the date of the latest meeting. All recorded changes
The ballot of 13 Jun 2024
126 filers reported votes at this meeting in the year to 30 June 2024. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.
Item 1: Director elections
2 nominees. 86.7% of the reported votes are for. 15 filers withheld from or voted against at least one nominee.
150 vote records from 48 filers. 2 of the 48 filers that marked the item voted against management.
- Positions of 23 fund families
- For 17
- Split or no vote 6
Item 2: Advisory vote on executive pay (say-on-pay)
168 vote records from 127 filers. 17 of the 123 filers that marked the item voted against management. 4 filers gave no management mark.
- Positions of 30 fund families
- For 26
- Against 4
- Against management 4
Item 3: Audit-related items (auditor ratification)
75 vote records from 48 filers. 1 of the 48 filers that marked the item voted against management.
- Positions of 23 fund families
- For 23
Positions of the fund families at the meeting of 13 Jun 2024
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | Say-on-pay |
|---|---|
| AllianceBernstein | For |
| American Century | Against, against management |
| Baird | For |
| BlackRock and iShares | For |
| BNY Mellon | For |
| Charles Schwab | For |
| Dimensional | Against, against management |
| DWS | For |
| Equitable | For |
| Federated Hermes | For |
| Fidelity | For |
| Global X | For |
| Goldman Sachs | For |
| Guggenheim and Rydex | For |
| Invesco | Against, against management |
| J.P. Morgan | For |
| John Hancock and Manulife | For |
| Lincoln Financial | For |
| Morgan Stanley, Eaton Vance and Calvert | Against, against management |
| Nationwide | For |
| Northern Trust and FlexShares | For |
| Nuveen and TIAA | For |
| Pacific Life funds | For |
| PGIM and Prudential | For |
| Principal | For |
| ProShares and ProFunds | For |
| State Street and SPDR | For |
| T. Rowe Price | For |
| Vanguard | For |
| Voya | For |
Every meeting on file
Say-on-pay, season by season
| Season | Filers reporting | Filers against management | Reported shares against management | |
|---|---|---|---|---|
| year to 30 June 2026 | 6 | not reported | not reported | |
| year to 30 June 2024 | 126 | 13.8% | 2.8% |
| Say-on-pay | This company | Median of companies on this site |
|---|---|---|
| Filers against management | not reported | 6.6% |
| Reported shares against management | not reported | 2.9% |
The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.
| Category | Vote records | Share |
|---|---|---|
| DIRECTOR ELECTIONS | 150 | 36.6% |
| SECTION 14A SAY-ON-PAY VOTES | 169 | 41.2% |
| AUDIT-RELATED | 75 | 18.3% |
| CAPITAL STRUCTURE | 8 | 2.0% |
| CORPORATE GOVERNANCE | 8 | 2.0% |
The record at the SEC
- SEC: Mutual Fund Proxy Voting Records and PoliciesThe SEC page on where to find the proxy voting record of a fund.
- SEC: Form N-PX and its instructions (PDF)The form that funds and managers file, with its instructions and the vote categories.
- SEC: final rule on enhanced reporting of proxy votesThe 2022 rule that set the present form and the say-on-pay report of managers.
- EDGAR full text search, Form N-PXThe SEC search of filing text, set to Form N-PX.
Each link loaded on .
Cite this page
Vote Scores. How funds voted at Carisma Therapeutics Inc.. https://votescores.com/company/carisma-therapeutics-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .
Questions
- How many meetings of Carisma Therapeutics Inc. are on file?
- 2 meetings are on file, from 13 Jun 2024 to 5 Aug 2025. 1 meeting has 20 or more reporting filers and has its own page.
- Did filers report proposals from security holders at Carisma Therapeutics Inc.?
- Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2026. The ballot shows the items that filers did report.
- Is this the meeting result?
- No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Carisma Therapeutics Inc. reports the result of a vote on Form 8-K.
- How does the site group meetings and names?
- Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Carisma Therapeutics Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .